JW Lifescience Corporation (KRX:234080)
South Korea
· Delayed Price · Currency is KRW 13,660
-90 (-0.65%)
At close: Dec 5, 2025
JW Lifescience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 211,519 | 168,472 | 199,286 | 188,137 | 214,461 | 328,567 | Upgrade
|
| Market Cap Growth | 20.88% | -15.46% | 5.93% | -12.27% | -34.73% | 4.80% | Upgrade
|
| Enterprise Value | 234,573 | 157,490 | 227,270 | 221,603 | 261,011 | 360,376 | Upgrade
|
| Last Close Price | 13660.00 | 10880.00 | 12304.53 | 11176.16 | 12240.30 | 17697.16 | Upgrade
|
| PE Ratio | 4.44 | 3.83 | 7.08 | 12.58 | 16.61 | 18.99 | Upgrade
|
| Forward PE | - | 9.92 | 9.92 | 9.92 | 9.92 | 13.92 | Upgrade
|
| PS Ratio | 0.85 | 0.76 | 0.96 | 1.00 | 1.26 | 1.79 | Upgrade
|
| PB Ratio | 0.98 | 0.84 | 1.25 | 1.34 | 1.63 | 2.48 | Upgrade
|
| P/TBV Ratio | 1.53 | 1.37 | 1.28 | 1.38 | 1.69 | 2.57 | Upgrade
|
| P/FCF Ratio | 7.68 | 4.17 | 6.77 | 31.10 | 19.17 | 10.66 | Upgrade
|
| P/OCF Ratio | 5.14 | 3.32 | 5.30 | 13.32 | 7.11 | 7.03 | Upgrade
|
| EV/Sales Ratio | 0.94 | 0.71 | 1.10 | 1.17 | 1.54 | 1.96 | Upgrade
|
| EV/EBITDA Ratio | 3.62 | 3.05 | 4.90 | 5.27 | 6.27 | 6.97 | Upgrade
|
| EV/EBIT Ratio | 4.96 | 4.39 | 7.36 | 8.18 | 9.19 | 9.14 | Upgrade
|
| EV/FCF Ratio | 8.52 | 3.90 | 7.73 | 36.63 | 23.33 | 11.69 | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.35 | 0.29 | 0.48 | 0.35 | 0.28 | Upgrade
|
| Debt / EBITDA Ratio | 0.93 | 1.34 | 1.00 | 1.60 | 1.12 | 0.71 | Upgrade
|
| Debt / FCF Ratio | 1.77 | 1.72 | 1.57 | 11.11 | 4.16 | 1.19 | Upgrade
|
| Asset Turnover | 0.87 | 0.77 | 0.81 | 0.80 | 0.78 | 0.88 | Upgrade
|
| Inventory Turnover | 6.42 | 5.61 | 6.80 | 6.54 | 6.38 | 7.63 | Upgrade
|
| Quick Ratio | 0.79 | 0.87 | 0.89 | 1.03 | 0.45 | 0.54 | Upgrade
|
| Current Ratio | 1.21 | 1.32 | 1.14 | 1.31 | 0.77 | 0.82 | Upgrade
|
| Return on Equity (ROE) | 24.72% | 24.45% | 18.78% | 11.01% | 9.78% | 13.56% | Upgrade
|
| Return on Assets (ROA) | 7.70% | 7.71% | 7.58% | 7.17% | 8.19% | 11.86% | Upgrade
|
| Return on Capital (ROIC) | 9.21% | 9.43% | 9.34% | 8.78% | 10.24% | 14.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.50% | 14.60% | 19.10% | 15.70% | 21.00% | 27.20% | Upgrade
|
| Earnings Yield | 22.50% | 26.11% | 14.12% | 7.95% | 6.02% | 5.27% | Upgrade
|
| FCF Yield | 13.02% | 23.97% | 14.76% | 3.21% | 5.22% | 9.38% | Upgrade
|
| Dividend Yield | 3.66% | 4.60% | 4.06% | 4.47% | 4.08% | 2.83% | Upgrade
|
| Payout Ratio | 16.27% | 17.60% | 27.51% | 51.75% | 61.31% | 45.76% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | - | - | 0.61% | 1.61% | - | Upgrade
|
| Total Shareholder Return | 3.67% | 4.60% | 4.06% | 5.09% | 5.69% | 2.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.